Mercer Global Advisors Inc. ADV Acquires 2,866 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mercer Global Advisors Inc. ADV increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,273 shares of the medical equipment provider's stock after buying an additional 2,866 shares during the quarter. Mercer Global Advisors Inc. ADV's holdings in Intuitive Surgical were worth $28,850,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of ISRG. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $82,517,000. Sycomore Asset Management increased its stake in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after acquiring an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after acquiring an additional 525 shares during the period. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock valued at $132,657,000 after purchasing an additional 114,149 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.5 %

NASDAQ:ISRG traded up $2.66 during trading hours on Wednesday, hitting $533.12. 421,104 shares of the company were exchanged, compared to its average volume of 1,620,754. The stock has a market capitalization of $191.08 billion, a price-to-earnings ratio of 83.21, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The company has a fifty day simple moving average of $502.67 and a 200 day simple moving average of $534.43. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the firm earned $1.50 EPS. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Truist Financial lowered their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $598.95.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,313 shares of company stock valued at $17,229,143. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.